Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.
Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective as [...]
¶
Posted 18 February 2009
† P. Driscoll
§
ablation § biomaterials § biotech § cancer § cardiology § diabetes § diagnostics § drug § gastroenterology § innovation § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § pharmaceutical § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: ablation, anti-adhesion, cancer, cardiology, cyanoacrylate, diabetes, disc replacement, drug, fibrin glue, fibrin sealant, gastroenterology, hemostasis, innovation, market data, medical adhesive, medtech, microwave ablation, neurology, obesity, ophthalmology, orthopedic, radiofrequency ablation, spine surgery, startups, surgical glue, surgical sealant, suture, thermal ablation, tissue engineering, ultrasound, urogenital, wound closure, wound management
If one is in the position of needing to look to the future of medical technology (and who in this industry is not?)—to identify opportunities or predict challenges in the market—then it is hard to not factor into it two very different current trends and play them out toward the resulting future market impact. One [...]
While this is separately a White Paper that I wrote and periodically re-write to reflect new stuff being developed (or progressing in that development), it is worthwhile to occasionally revisit the list of technologies that have real promise, especially if that promise is getting closer to reality, or only if the demand is simply getting [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation:Â An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
¶
Posted 13 May 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, innovation, market data, medtech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
¶
Posted 09 April 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § gastroenterology § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, gastroenterology, innovation, market data, medtech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
(From the September 2007 issue of MedMarkets)
Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note those [...]
¶
Posted 26 September 2007
† P. Driscoll
§
biotech § cancer § cardiology § gastroenterology § market data § medtech § nanotech § neurology § obesity § orthopedic § surgery § tissue engineering
‡
°
Also tagged: biotech, cancer, cardiology, gastroenterology, market data, medtech, neurology, obesity, orthopedic, surgery, tissue engineering
It has already been said that medical technology is getting complicated. Now it’s time to point out that the world is getting strikingly small(er).
Even the youngest startup has to consider market opportunity on a global scale. So a little medtech startup with not much more than a patent (and sometimes not even that) and with [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
In initiating our report on “Micro- and Nanomedicine“, which details the full spectrum of products, technologies and markets in the application of MEMS and nanotech to medical use, I elected not to approach this as an update of the report we did in 2003, for several reasons. First, I was able to draw on very [...]
The potential for nanomedicne, the medical application of nanotechnology, is vast, as has been pronounced almost endlessly since it was conceived. However, already on the market in the United States are wound dressings that exploit the antimicrobial properties of nanocrystalline silver, and nanotech-based products for drug delivery, materials technologies and other nanomedical applications are indeed [...]